4th GANSID Congress 2026 concluded in Hyderabad; Global Experts Unite to Address Inherited Blood Disorders
Hyderabad : The 4th GANSID Congress 2026, a three-day international conference focusing on sickle cell disease, thalassemia and other inherited blood disorders, was held from 23 to 25 October 2026 at the Hyderabad International Convention Centre (HICC)–Novotel, Madhapur, Hyderabad. The congress brought together national and international medical experts, researchers, healthcare professionals, policymakers, patient organisations and other stakeholders to strengthen collaborative efforts towards the prevention, early diagnosis, treatment and management of inherited blood disorders.
The inaugural ceremony was graced by Mr. Vinod K. Agrawal, Retired IAS Officer, as the Chief Guest. The distinguished guests included Mrs. Vinita Srivastava, National Health Authority, Government of India; Dr. Pankaj Gupta, Pfizer India; Dr. Dipty Jain, Co-Chair of the GANSID Congress; Dr. Jameela Sather, Co-Chair of the GANSID Congress; and Dr. Suman Jain, CEO of the Thalassemia and Sickle Cell Society (TSCS), Hyderabad, Mrs. Ratnavali – Sr. Vice President -TSCS, Aleem Baig, Joint Secretary – TSCS, Manoj Rupani, Treasurer along with Naresh Rathi and all board members of TSCS.
The inaugural session was moderated by Mrs. Lanre Tunji-Ajayi, M.S.M., Chief Executive Officer of the Global Action Network for Sickle Cell and Other Inherited Blood Disorders (GANSID). Welcoming the dignitaries and delegates, she highlighted the importance of bringing together diverse stakeholders to address the medical, social and healthcare challenges associated with inherited blood disorders.
Strong International and National Participation
Mrs. Lanre Tunji-Ajayi expressed her appreciation for the encouraging participation at the congress, particularly the presence of more than 70 international delegates representing 23 countries. She also acknowledged the strong participation of delegates from across India, reflecting a growing commitment to improving the prevention, diagnosis, treatment and care of people affected by inherited blood disorders.
The participation of international experts, Indian healthcare professionals, researchers, patient organisations, policymakers and representatives from various institutions provided a valuable platform for exchanging scientific knowledge, sharing experiences and building partnerships. The congress facilitated discussions on emerging medical developments, equitable access to quality healthcare and coordinated approaches to addressing the medical and social challenges faced by individuals living with sickle cell disease, thalassemia and other inherited blood disorders.
TSCS Hyderabad: Strengthening Patient Care and Support
The Thalassemia and Sickle Cell Society (TSCS), Hyderabad, served as the local partner for the GANSID Congress 2026. A non-profit organisation, TSCS supports more than 4,800 patients affected by thalassemia, sickle cell disease and other inherited blood disorders. The society undertakes a range of initiatives, including blood transfusion support, awareness and prevention programmes, antenatal screening, patient counselling and financial assistance for bone marrow transplantation. Through its collaboration with GANSID, TSCS aims to strengthen international cooperation, promote public awareness, facilitate the exchange of medical knowledge and encourage the development of accessible and effective healthcare services for patients and their families.
A Collective Commitment to a Healthier Future
The successful conclusion of the 4th GANSID Congress 2026 marks an important step towards strengthening global cooperation in addressing inherited blood disorders. Participation by delegates from 23 countries, alongside strong representation from across India, underscored the importance of coordinated action involving medical professionals, researchers, policymakers, patient organisations and healthcare institutions.
The three-day congress provided opportunities for scientific discussions, professional networking and collaborative engagement, with a shared focus on improving prevention, early diagnosis, treatment and long-term care. The event reaffirmed the collective commitment of participating organisations and healthcare stakeholders to improving access to quality care, strengthening patient support systems and enhancing the quality of life of individuals affected by sickle cell disease, thalassemia and other inherited blood disorders.
Issued by: Global Action Network for Sickle Cell and Other Inherited Blood Disorders (GANSID), in collaboration with the Thalassemia and Sickle Cell Society (TSCS), Hyderabad.
****
